APOBIOLOGIX
Apobiologix is a pharmaceutical company. They are suppliers of affordable pharmaceutical products. They focus on culture of quality and its commitment to manufacturing safe and effective medicines, meeting strict regulatory standards and making healthcare accessible to millions of people worldwide. They aspire to transform access to affordable therapies in oncology and beyond through innovation, development and partnerships.
APOBIOLOGIX
Social Links:
Industry:
Biotechnology Emergency Medicine Health Care Pharmaceutical Retail
Founded:
2007-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.apobiologix.com
Total Employee:
101+
Status:
Active
Contact:
+1 855 276 7744
Technology used in webpage:
Google Tag Manager SSL By Default Global Site Tag Google Analytics 4 US Privacy User Signal Mechanism IIS 10 GoDaddy SSL Canadian Server Location
Similar Organizations
Aspire Pharmaceuticals
Aspire Pharmaceuticals is a pharmaceutical company providing nutritional soft gelatin supplements.
Enclara Pharmacia
Enclara Pharmacia offers clinical services, operation processes, and educational programs to improve patient care.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Official Site Inspections
http://www.apobiologix.com Semrush global rank: 5.48 M Semrush visits lastest month: 1.34 K
- Host name: www.mediplast.ca
- IP address: 209.29.196.235
- Location: Mississauga Canada
- Latitude: 43.599
- Longitude: -79.6885
- Timezone: America/Toronto
- Postal: L5V
More informations about "Apobiologix"
Our Commitment - Apobiologix
Our Mission. Apobiologix ®, a division of Apotex Inc., focuses on the commercialization of biosimilars.The Apobiologix ® biosimilar program is a natural extension of Apotex' long history …See details»
Apobiologix - Crunchbase Company Profile & Funding
Apobiologix is a pharmaceutical company. They are suppliers of affordable pharmaceutical products. They focus on culture of quality and its commitment …See details»
Patient Support - Apobiologix
ANSWERS is a comprehensive patient support program dedicated to helping Canadian patients who are prescribed an Apobiologix product gain access to their medication as quickly as …See details»
Apobiologix - LinkedIn
Apobiologix is a member of the Apotex Group of Companies, the largest Canadian-owned, pharmaceutical company with sales in 115 countries across the world. Founded in 1974 by Dr. Barry Sherman ...See details»
Apobiologix - The Org
Apobiologix is a member of the Apotex Group of Companies, the largest Canadian-owned, pharmaceutical company with sales in 115 countries across the world. Founded in 1974 by Dr. …See details»
Apobiologix - 2025 Company Profile - Tracxn
Mar 22, 2025 Apobiologix develops biosimilar therapeutics for cancer and auto-immune diseases. Its lead candidate Grastofil is a biosimilar for filgrastim (Neupogen) that has been …See details»
Apobiologix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Apobiologix, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 9 news, and 1 literature.See details»
Apobiologix - Contacts, Employees, Board Members, Advisors
Apobiologix is a biosimilar company that brings additional medicines to patients.See details»
Our Leadership - Apobiologix
Mike Woolcock serves as senior vice president of Apobiologix, a leader in biologic innovation and biosimilar development. Mike has more than 30 years of experience managing …See details»
Apobiologix - Overview, News & Similar companies - ZoomInfo
Apobiologix, a part of the Apotex group focused on biologics innovation, is a pioneer in the field of biosimilars. The company has a robust pipelin e of biologic products, and aims at providing …See details»
Apobiologix - VentureRadar
Apobiologix VentureRadar profile. Find out more about Apobiologix, Biologics.See details»
Apotex Builds Momentum in Canada's Biosimilar Market After …
Jun 1, 2018 The company that is focused on the development of biosimilars for global markets, recently received approval from Health Canada for Apobiologix's latest product addition, …See details»
Apotex/Apobiologix: Success in Canada, but Are They Shelving ...
May 8, 2019 In April 2018, we spoke with Apobiologix executives, who told us that the company “were still in discussions with the FDA” about the path forward for its G-CSF biosimilars. …See details»
Canadian Cancer Patients Have New Affordable Treatment Option
Sep 27, 2021 Apobiologix was the first company to offer a portfolio of G-CSF biosimilars. "Biosimilars provide an opportunity for the sustainability of global healthcare systems by ...See details»
Resources & Contact - Apobiologix
Apobiologix Canada Customer Service Phone: 1-855-APO (276)-7744 Email. Answers Program Phone: 1-866-APO (276)-1664 Website: www.apoanswers.ca Email. To report an adverse …See details»
Biologics & Biosimilars Collective Intelligence Consortium (BBCIC ...
Alexandria, Va., Jan. 25, 2017 — The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) is pleased to announce the addition of a new participating organization, Apobiologix. …See details»
Our Portfolio - Apobiologix
Apobiologix continues to invest in oncology biosimilars and expanding our portfolio to new therapeutic areas. Our focus remains on an unwavering commitment to transforming access in …See details»
Apotex Builds Momentum in Canada's Biosimilar Market After …
Jun 1, 2018 Health Canada Leads the Way by Approving the First-Ever Pegfilgrastim Biosimilar in any Highly Regulated World Market. Toronto, ON, June 1st - 2018 - Apobiologix, a division …See details»
Patient Access to Affordable Cancer Treatment Increases with
Nov 9, 2021 Apobiologix's strategic partnership with Spanish-based biotechnology company mAbxience, supports the company's mission to transform access to affordable therapies in …See details»